An interpretable deep learning framework identifies proteomic drivers of Alzheimer’s disease
Authors:
Open Access
- 17 September 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 12, 1379984
Abstract
Alzheimer’s disease (AD) is the leading neurodegenerative pathology in aged individuals, but many questions remain on its pathogenesis, and a cure is still not available. Recent research efforts have generated measurements of multiple omics in individuals that were healthy or diagnosed with AD. Although machine learning approaches are well-suited to handle the complexity of omics data, the models typically lack interpretability. Additionally, while the genetic landscape of AD is somewhat more established, the proteomic landscape of the diseased brain is less well-understood. Here, we establish a deep learning method that takes advantage of an ensemble of autoencoders (AEs) — EnsembleOmicsAE–to reduce the complexity of proteomics data into a reduced space containing a small number of latent features. We combine brain proteomic data from 559 individuals across three AD cohorts and demonstrate that the ensemble autoencoder models generate stable latent features which are well-suited for downstream biological interpretation. We present an algorithm to calculate feature importance scores based on the iterative scrambling of individual input features (i.e., proteins) and show that the algorithm identifies signaling modules (AE signaling modules) that are significantly enriched in protein–protein interactions. The molecular drivers of AD identified within the AE signaling modules derived with EnsembleOmicsAE were missed by linear methods, including integrin signaling and cell adhesion. Finally, we characterize the relationship between the AE signaling modules and the age of death of the patients and identify a differential regulation of vimentin and MAPK signaling in younger compared with older AD patients.Keywords
Funding Information
- National Institutes of Health (GM152206)
This publication has 84 references indexed in Scilit:
- 2024 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2024
- Autoencoders2023
- Hypertension-induced synapse loss and impairment in synaptic plasticity in the mouse hippocampus mimics the aging phenotype: implications for the pathogenesis of vascular cognitive impairmentGeroScience, 2017
- Biomarkers for the Early Detection and Progression of Alzheimer's DiseaseNeurotherapeutics, 2017
- The Cellular Phase of Alzheimer’s DiseaseCell, 2016
- GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild‐type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's diseaseGlia, 2015
- Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous systemCurrent Opinion in Cell Biology, 2015
- Neuronal expression of vimentin in the Alzheimer's disease brain may be part of a generalized dendritic damage-response mechanismBrain Research, 2009
- Role of Genes and Environments for Explaining Alzheimer DiseaseArchives of General Psychiatry, 2006
- Intermediate filaments in the nervous system: implications in cancerCancer and Metastasis Reviews, 1996